We are live on ! Find out more
SC

Sculptor Capital Portfolio holdings

AUM $9.61B
1-Year Est. Return 27.49%
This Fund
S&P 500
This Quarter Est. Return
+17.11%
1 Year Est. Return
+27.49%
3 Year Est. Return
+96.6%
5 Year Est. Return
+118.13%
10 Year Est. Return
+298.34%
AUM
$16.8B
AUM Growth
+$1.6B
Cap. Flow
-$662M
Cap. Flow %
-3.93%
Top 10 Hldgs %
64.32%
Holding
323
New
94
Increased
34
Reduced
54
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 10.82%
2 Consumer Discretionary 7.02%
3 Communication Services 5.97%
4 Financials 4.75%
5 Industrials 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTC icon
126
PUT
Elastic
ESTC
$6.7B
$1.52M 0.01%
+19,000
New +$1.59M
EOLS icon
127
PUT
Evolus
EOLS
$397M
$1.5M 0.01%
+66,300
New +$1.43M
INSG icon
128
Inseego
INSG
$104M
$1.46M 0.01%
+31,010
New +$1.58M
INSG icon
129
PUT
Inseego
INSG
$104M
$1.46M 0.01%
+31,010
New +$1.58M
GTT
130
DELISTED
GTT Communications, Inc.
GTT
$1.4M 0.01%
40,400
-103,700
-72% -$3.04M
GTT
131
PUT
DELISTED
GTT Communications, Inc.
GTT
$1.4M 0.01%
40,400
-103,700
-72% -$3.04M
CRON
132
Cronos Group
CRON
$1.07B
$1.3M 0.01%
70,800
-25,000
-26% -$469K
CRON
133
PUT
Cronos Group
CRON
$1.07B
$1.3M 0.01%
70,800
-35,300
-33% -$663K
FPAC.WS
134
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
$1.3M 0.01%
1,000,000
NBEV
135
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.3M 0.01%
246,300
+239,300
+3,419% +$1.44M
AXDX
136
DELISTED
Accelerate Diagnostics
AXDX
$1.26M 0.01%
+6,000
New +$1.12M
AXDX
137
PUT
DELISTED
Accelerate Diagnostics
AXDX
$1.26M 0.01%
+6,000
New +$1.12M
NBEV
138
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.24M 0.01%
+236,300
New +$1.42M
SONO icon
139
Sonos
SONO
$2.09B
$1.15M 0.01%
112,000
-10,400
-8% -$113K
SONO icon
140
PUT
Sonos
SONO
$2.09B
$1.15M 0.01%
112,000
-37,900
-25% -$411K
LQDA icon
141
Liquidia Corp
LQDA
$7.72B
$1.14M 0.01%
+100,000
New +$1.6M
BILI icon
142
PUT
Bilibili
BILI
$7.75B
$1.14M 0.01%
60,000
-38,000
-39% -$665K
BILI icon
143
Bilibili
BILI
$7.75B
$1.11M 0.01%
58,700
-38,000
-39% -$665K
CRBP icon
144
Corbus Pharmaceuticals
CRBP
$165M
$1.04M 0.01%
+5,000
New +$1.1M
CRBP icon
145
PUT
Corbus Pharmaceuticals
CRBP
$165M
$1.04M 0.01%
+5,000
New +$1.1M
TCRT icon
146
Alaunos Therapeutics
TCRT
$4.64M
$985K 0.01%
1,705
+240
+16% +$100K
TCRT icon
147
PUT
Alaunos Therapeutics
TCRT
$4.64M
$985K 0.01%
1,705
+240
+16% +$100K
TBCH
148
PUT
Turtle Beach Corp
TBCH
$238M
$971K 0.01%
85,500
+58,300
+214% +$879K
TBCH
149
Turtle Beach Corp
TBCH
$238M
$926K 0.01%
81,500
+54,300
+200% +$818K
IPOA.WS
150
DELISTED
Social Capital Hedosophia Holdings Corp. Warrants, each whole warrant exercisable for one Class A Or
IPOA.WS
$910K 0.01%
1,166,666

Similar funds

Sculptor Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Sculptor Capital held 323 positions worth $16.8B, up 11% from $15.2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sculptor Capital withdrew a net $662M in Q1 2019, closing 99 positions and reducing 54 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $3.4B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Sculptor Capital opened a new position in Celgene Corp worth $158M.

  • Sculptor Capital's largest Q1 2019 buy was Celgene Corp: 1,674,764 shares worth $158M.
  • Sculptor Capital added most to NXP Semiconductors in Q1 2019, an estimated $307M increase.
  • Sculptor Capital's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $101M.
  • Sculptor Capital fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $3.4B.
  • Sculptor Capital's ten largest holdings make up 64% of its $16.8B portfolio in Q1 2019.
  • Sculptor Capital opened 94 new positions and closed 99 in Q1 2019.
  • Sculptor Capital's portfolio value rose 11% quarter-over-quarter to $16.8B.

Based on Sculptor Capital's 13F filing for Q1 2019, filed 13 May 2019.